FREQUENT BASELINE EGFR MUTATION T790M IN CYTOLOGICAL SPECIMENS OF TYROSINE KINASE INHIBITOR (TKI) NAIVE ADENOCARCINOMA NSCLC PATIENTS

被引:0
|
作者
Andarini, S. L. [1 ]
Zaini, J. [1 ]
Hudoyo, A. [1 ]
Hidayat, H. [1 ]
Widjajahakim, G. [2 ]
Utomo, A. R. [3 ]
机构
[1] Univ Indonesia, Persahabatan Hosp, Dept Pulmonol & Resp Med, Fac Med, Jakarta, Indonesia
[2] KalGen Lab, Pathol Core Facil, Jakarta, Indonesia
[3] KalGen Lab, Stem Cell & Canc Inst, Canc Diagnost Res, Jakarta, Indonesia
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
APSR6-0587
引用
收藏
页码:79 / 79
页数:1
相关论文
共 50 条
  • [11] Progressive Disease with T790M Mutation vs Non-T790M Mutation in EGFR Positive Patients Treated with Tyrosine Kinase Inhibitors
    Reis, D.
    China, N.
    Dias, M.
    Coutinho, D.
    Silva, E.
    Campainha, S.
    Costa, T.
    Conde, S.
    Cirnes, L.
    Barroso, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S942 - S943
  • [12] Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient with EGFR TKI Drug Resistance
    Xu, S.
    Liu, X.
    Liu, R.
    Shi, T.
    Li, X.
    Zhong, D.
    Wang, Y.
    Chen, G.
    Chen, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2201 - S2201
  • [13] T790M MUTATION ASSOCIATED WITH BETTER EFFICACY OF CONTINUOUS EGFR-TKI TREATMENT IN ADVANCED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Ren, Shengxiang
    Li, Wei
    Li, Aiwu
    Chen, Xiaoxia
    Gao, Guanghui
    He, Yayi
    Li, Xuefei
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1084 - S1084
  • [14] Germline T790M Mutation of the Epidermal Growth Factor Receptor (EGFR) in a Case of Multifocal Adenocarcinoma of the Lung Without Exposure to Tyrosine Kinase Inhibitors (TKI)
    Azab, M.
    Al-Dawoodi, T.
    Romero, A. O.
    Vogelzang, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [15] Acquired T790M mutation after first generation EGFR tyrosine kinase retreatment
    Lee, Sung Yong
    Oh, Jee Youn
    Shim, Jae Jeong
    Kang, Kyung Ho
    Min, Kyung Hoon
    CANCER RESEARCH, 2018, 78 (13)
  • [16] Correlation between re-biopsy site and detection of T790M mutation in NSCLC patients treated with EGFR TKI
    Shigematsu, Fumie
    Kogure, Yoshihito
    Saka, Hideo
    Yamada, Arisa
    Ishida, Akane
    Ise, Yuko
    Hori, Kazumi
    Oka, Saori
    Nakahata, Masashi
    Kitagawa, Chiyoe
    Oki, Masahide
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [17] Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M
    Zhao, S.
    Jiang, T.
    Li, X.
    Zhao, C.
    Su, C.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S410 - S410
  • [18] T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients
    Li, Wei
    Ren, Shengxiang
    Li, Jiayu
    Li, Aiwu
    Fan, Lihong
    Li, Xuefei
    Zhao, Cao
    He, Yayi
    Gao, Guanghui
    Chen, Xiaoxia
    Li, Shuai
    Shi, Jingyun
    Zhou, Caicun
    Fei, Ke
    Schmid-Bindert, Gerald
    LUNG CANCER, 2014, 84 (03) : 295 - 300
  • [19] Highly Sensitive Detection of EGFR T790M Mutation in Pre-TKI Specimens of EGFR-Mutated NSCLC: In Cis, In Trans, or a Different Clone?
    Leone, Alvaro
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : E26 - E27
  • [20] Uncommon EGFR mutations associate with lower incidence of T790M mutation after EGFR-TKI treatment in patients with advanced NSCLC
    Yang, Shuo
    Mao, Shiqi
    Li, Xuefei
    Zhao, Chao
    Liu, Qian
    Yu, Xiaofei
    Wang, Yan
    Liu, Yiwei
    Pan, Yingying
    Wang, Chunyan
    Gao, Guanghui
    Li, Wei
    Xiong, Anwen
    Chen, Bin
    Sun, Hui
    He, Yayi
    Wu, Fengying
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    LUNG CANCER, 2020, 139 : 133 - 139